Loren Data's SAM Daily™

Home Today's SAM Search Archives Numbered Notes CBD Archives Subscribe

B -- Investigation of an Unexplained Dermopathy, California

Notice Date
Notice Type
Solicitation Notice
621498 — All Other Outpatient Care Centers
Contracting Office
Department of Health and Human Services, Center for Disease Control and Prevention, Procurement and Grants Office (Atlanta), 2920 Brandywine Road, Room 3000, Atlanta, GA, 30341-4146, UNITED STATES
ZIP Code
Solicitation Number
Response Due
Archive Date
The Centers for Disease Control and Prevention (CDC), Coordinating Center for Infectious Diseases (CCID), National Center for Preparedness, Detection, and Control of Infectious Diseases (NCPDCID), Division of Healthcare Quality Promotion is seeking to award a sole source commercial contract for investigation in California of an unexplained dermopathy (Skin Condition)called Morgellons. The Government has determined that Kaiser Permanente (KP), Northern California is the only responsible source to meet the Government's needs. Morgellons is a rare condition with a heavy concentration in California, and KP is the only organization that has the location, coverage area, and membership size to provide the large sample size required for the study. Minimum HMO membership required to satisfy this study is %25 of the population in the region selected. Other minimum vendor qualifications for this requirement are: Electronic health records that have been implemented in the organization at least since January 2006; Ability to conduct electronic queries of medical records, including progress notes, to identify clinical conditions and complaints; Health maintenance organization with at least 3 million enrollees and coverage of at least 25% of the population in the chosen geographic area; Location in a geographic area with a large number of suspected cases; Experience in conducting clinical and epidemiologic studies; Adequate qualified personnel to successfully perform the requested services by the date required. The proposed effort will involve the following: describing the clinical and epidemiologic features of persons who have reported themselves as having this unexplained skin condition, including assessing the frequency of co-morbid conditions (e.g., neurocognitive deficits, neurologic conditions, major psychiatric disorders); collecting information to generate hypotheses about possible risk factors for this condition; assessing the histopathologic features of the skin condition based on skin biopsies from a sample of affected patients; characterizing fibers or threads obtained from patients with the condition to determine their potential etiology; describing the geographic distribution and estimate rates of illness; and describing health care utilization among persons with the condition. Total period of performance will be seven (7) months from date of award. The Government intends to issue a Request for Quotation (RFQ) on 31 July 2007, with award anticipated by 31 August 2007. All responsible sources may submit a bid, proposal, or quotation which shall be considered by the agency.
SN01342706-W 20070716/070714220302 (fbodaily.com)
FedBizOpps Link to This Notice
(may not be valid after Archive Date)

FSG Index  |  This Issue's Index  |  Today's FBO Daily Index Page |
ECGrid: EDI VAN Interconnect ECGridOS: EDI Web Services Interconnect API Government Data Publications CBDDisk Subscribers
 Privacy Policy  © 1994-2020, Loren Data Corp.